Latest ONCT reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Oncternal Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Oncternal Therapeutics logo
Oncternal Therapeutics ONCT
$ 8.1 1.25%
mail-toReport an Error

Oncternal Therapeutics EV/EBITDA Ratio 2011-2024 | ONCT

Annual EV/EBITDA Ratio Oncternal Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.32 0.446 -1.24 0.186 -8.46 -2.67 -3.67 -1.06 -2.29 -5.32 -8.38

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.32 -8.46 -2.83